Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02716896 · ClinicalTrials.gov registry record · NA
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02716896 is a NA study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 2 participants.
The verdict
NCT02716896, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Radical cystectomy is fraught with complications and risk of death. The researchers hope to learn if chemoradiation (i.e. using chemotherapy and radiation), also an acceptable treatment for muscle invasive bladder cancer, can be used a good alternative therapy option.
Interventions
- PROCEDURE Radical cystectomy
- RADIATION Radiation and chemoradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02716896
The ClinicalTrials.gov registry entry for NCT02716896 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radical cystectomy is the first listed.
NCT02716896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02716896 about?
NCT02716896 is a clinical study titled "Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer". Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Radical cystectomy is fraught with complications and risk of death. The researchers hope to learn if chemoradiation (i.e. using chemotherapy and rad...
What is the current status of trial NCT02716896?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-05. Estimated completion is 2018-03-26.
What interventions are being tested in trial NCT02716896?
The interventions under investigation include: Radical cystectomy (PROCEDURE), Radiation and chemoradiation (RADIATION).
Who is sponsoring clinical trial NCT02716896?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.